Advertisement

Index by Author

July 1999; 48 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adkison, K

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  2. Agarwal, R K

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

  3. Akerblom, H K

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  4. Alejandro, R

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Anai, M

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  6. Asano, T

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  7. Avendano, G F

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

B

  1. Bashey, R I

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

  2. Becker, D J

    • Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes July 1999 48:1454-1458; doi:10.2337/diabetes.48.7.1454

  3. Becker, K G

    • Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes July 1999 48:1353-1358; doi:10.2337/diabetes.48.7.1353

  4. Berho, M

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Binz, J G

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  6. Björklund, A

    • Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes July 1999 48:1409-1414; doi:10.2337/diabetes.48.7.1409

  7. Blanchard, S G

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  8. Brown, H R

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  9. Brown, K K

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  10. Buckingham, R E

    • The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes July 1999 48:1448-1453; doi:10.2337/diabetes.48.7.1448

  11. Burkly, L C

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

C

  1. Carroll, R J

    • Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes July 1999 48:1395-1401; doi:10.2337/diabetes.48.7.1395

  2. Chan, C B

    • Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes July 1999 48:1482-1486; doi:10.2337/diabetes.48.7.1482

  3. Chattington, P D

    • The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes July 1999 48:1448-1453; doi:10.2337/diabetes.48.7.1448

  4. Chatzipetrou, M

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Chinookoswong, N

    • Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes July 1999 48:1487-1492; doi:10.2337/diabetes.48.7.1487

  6. Cobb, J E

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  7. Colantuoni, V

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

  8. Cryer, P E

    • Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia. Diabetes July 1999 48:1429-1436; doi:10.2337/diabetes.48.7.1429

D

  1. de Groot, M

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  2. De Haan, B J

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  3. De Vos, P

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  4. Dvorak, R V

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

E

  1. Egawa, K

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  2. Evans, R W

    • Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes July 1999 48:1454-1458; doi:10.2337/diabetes.48.7.1454

F

  1. Faison, W

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  2. Fanelli, C G

    • Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia. Diabetes July 1999 48:1429-1436; doi:10.2337/diabetes.48.7.1429

  3. Fernandez, L A

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  4. Forrest, K Y

    • Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes July 1999 48:1454-1458; doi:10.2337/diabetes.48.7.1454

  5. Fridkin, M

    • New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin. Diabetes July 1999 48:1437-1442; doi:10.2337/diabetes.48.7.1437

  6. Fukushima, Y

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  7. Funaki, M

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  8. Furukawa, H

    • Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes July 1999 48:1395-1401; doi:10.2337/diabetes.48.7.1395

G

  1. Gao, Z Y

    • Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death. Diabetes July 1999 48:1372-1380; doi:10.2337/diabetes.48.7.1372

  2. Gershonov, E

    • New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin. Diabetes July 1999 48:1437-1442; doi:10.2337/diabetes.48.7.1437

  3. Goldberg, J L

    • Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes July 1999 48:1359-1364; doi:10.2337/diabetes.48.7.1359

  4. Grill, V

    • Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes July 1999 48:1409-1414; doi:10.2337/diabetes.48.7.1409

H

  1. Hämäläinen, A M

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  2. Han, D

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  3. Haneda, M

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  4. Harlan, D M

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Harrington, W W

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  6. Hashim, M A

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  7. Hauge-Evans, A C

    • Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes July 1999 48:1402-1408; doi:10.2337/diabetes.48.7.1402

  8. Henke, B R

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  9. Hidaka, H

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

I

  1. Iaria, G

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  2. Ilonen, J

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  3. Inukai, K

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  4. Inverardi, L

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Iwai, N

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

J

  1. Johns, D C

    • Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes July 1999 48:1482-1486; doi:10.2337/diabetes.48.7.1482

  2. Jones, P M

    • Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes July 1999 48:1402-1408; doi:10.2337/diabetes.48.7.1402

  3. Jyothirmayi, G N

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

K

  1. Kaldor, I

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  2. Kashiwagi, A

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  3. Katagiri, H

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  4. Kenyon, N S

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Kikkawa, R

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  6. Kikuchi, M

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  7. Kim, J

    • Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes July 1999 48:1459-1465; doi:10.2337/diabetes.48.7.1459

  8. Kinoshita, M

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  9. Kirk, A D

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  10. Kliewer, S A

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  11. Knip, M

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  12. Kojima, H

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

L

  1. Lehmann, J M

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  2. Lehmann, R

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  3. Lenhard, J M

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  4. Lopes-Virella, M F

    • Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes July 1999 48:1454-1458; doi:10.2337/diabetes.48.7.1454

  5. Lyons, M M

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

M

  1. MacDonald, P E

    • Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes July 1999 48:1482-1486; doi:10.2337/diabetes.48.7.1482

  2. Maegawa, H

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  3. Major, C D

    • Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death. Diabetes July 1999 48:1372-1380; doi:10.2337/diabetes.48.7.1372

  4. Mancini, F P

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

  5. Marbàn, E

    • Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes July 1999 48:1482-1486; doi:10.2337/diabetes.48.7.1482

  6. Masetti, M

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  7. Matthews, D E

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

  8. Menius, J A

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  9. Mintz, D H

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  10. Mitchell, J J

    • Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes July 1999 48:1359-1364; doi:10.2337/diabetes.48.7.1359

  11. Mook, R

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  12. Munoz-Elias, E J

    • Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes July 1999 48:1459-1465; doi:10.2337/diabetes.48.7.1459

  13. Muona, P

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

N

  1. Nakamura, Y

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  2. Navas, M A

    • Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes July 1999 48:1459-1465; doi:10.2337/diabetes.48.7.1459

  3. Nieuwenhuizen, A G

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  4. Nishio, Y

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  5. Noble, S A

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  6. Novak, P J

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

O

  1. Ogihara, T

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  2. Oka, Y

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  3. Oliver, W O

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  4. Onishi, Y

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  5. Ono, H

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  6. Orchard, T J

    • Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes July 1999 48:1454-1458; doi:10.2337/diabetes.48.7.1454

P

  1. Paramore, D S

    • Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia. Diabetes July 1999 48:1429-1436; doi:10.2337/diabetes.48.7.1429

  2. Parks, D J

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  3. Paronen, J

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  4. Persaud, S J

    • Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes July 1999 48:1402-1408; doi:10.2337/diabetes.48.7.1402

  5. Ploeg, R J

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  6. Plunket, K D

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  7. Poehlman, E T

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

Q

  1. Qiao, L Y

    • Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes July 1999 48:1359-1364; doi:10.2337/diabetes.48.7.1359

R

  1. Ranuncoli, A

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  2. Regan, T J

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

  3. Riccardi, G

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

  4. Ricordi, C

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  5. Rivellese, A A

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

  6. Ruiz, P

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

S

  1. Sabatino, L

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

  2. Sakoda, H

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

  3. Saleh, M C

    • Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes July 1999 48:1482-1486; doi:10.2337/diabetes.48.7.1482

  4. Shah, S D

    • Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia. Diabetes July 1999 48:1429-1436; doi:10.2337/diabetes.48.7.1429

  5. Shechter, Y

    • New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin. Diabetes July 1999 48:1437-1442; doi:10.2337/diabetes.48.7.1437

  6. Shih, D

    • Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes July 1999 48:1459-1465; doi:10.2337/diabetes.48.7.1459

  7. Shi, K

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  8. Shi, Z Q

    • Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes July 1999 48:1487-1492; doi:10.2337/diabetes.48.7.1487

  9. Shuldiner, A R

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

  10. Silver, K

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

  11. Simell, O

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  12. Soni, B J

    • Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes July 1999 48:1443-1447; doi:10.2337/diabetes.48.7.1443

  13. Squires, P E

    • Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes July 1999 48:1402-1408; doi:10.2337/diabetes.48.7.1402

  14. Starling, R D

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

  15. Steiner, D F

    • Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes July 1999 48:1395-1401; doi:10.2337/diabetes.48.7.1395

  16. Stoffel, M

    • Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes July 1999 48:1459-1465; doi:10.2337/diabetes.48.7.1459

  17. Sun, X J

    • Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes July 1999 48:1359-1364; doi:10.2337/diabetes.48.7.1359

  18. Swift, H H

    • Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. Diabetes July 1999 48:1395-1401; doi:10.2337/diabetes.48.7.1395

T

  1. Tchernof, A

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

  2. Tong, W Q

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  3. Tufano, A

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

V

  1. Vaarala, O

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  2. Väätäinen, M

    • Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes July 1999 48:1389-1394; doi:10.2337/diabetes.48.7.1389

  3. Vaccaro, O

    • Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes July 1999 48:1466-1468; doi:10.2337/diabetes.48.7.1466

  4. Van Schilfgaarde, R

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  5. Van Straaten, J F

    • Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes July 1999 48:1381-1388; doi:10.2337/diabetes.48.7.1381

  6. Virella, G

    • Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes July 1999 48:1454-1458; doi:10.2337/diabetes.48.7.1454

W

  1. Wagner, J L

    • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes July 1999 48:1473-1481; doi:10.2337/diabetes.48.7.1473

  2. Walker, A B

    • The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes July 1999 48:1448-1453; doi:10.2337/diabetes.48.7.1448

  3. Walston, J D

    • Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women. Diabetes July 1999 48:1425-1428; doi:10.2337/diabetes.48.7.1425

  4. Wang, J L

    • Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes July 1999 48:1487-1492; doi:10.2337/diabetes.48.7.1487

  5. Wheeler, M B

    • Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes July 1999 48:1482-1486; doi:10.2337/diabetes.48.7.1482

  6. Williams, G

    • The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes July 1999 48:1448-1453; doi:10.2337/diabetes.48.7.1448

  7. Willson, T M

    • A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes July 1999 48:1415-1424; doi:10.2337/diabetes.48.7.1415

  8. Wolf, B A

    • Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death. Diabetes July 1999 48:1372-1380; doi:10.2337/diabetes.48.7.1372

Y

  1. Yasuda, H

    • The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes July 1999 48:1469-1472; doi:10.2337/diabetes.48.7.1469

  2. Yazaki, Y

    • No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes July 1999 48:1365-1371; doi:10.2337/diabetes.48.7.1365

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement